AGP Picks
View all

Somaliland Science Reporter
Provided by AGP

Somaliland Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Science Reporter.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 6, 2026

Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results
Aug. 6, 2026

Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Genius Group Launch First Phase of $14 Million Genius City Project in Nuanu, Bali
Aug. 6, 2026

Genius Group Launch First Phase of $14 Million Genius City Project in Nuanu, Bali

Indeterminate GlobeNewswire
Acorn’s Q2 EPS of $0.12 Reflects Increasing High-Margin, Recurring Monitoring Revenue; Growth Initiatives Include New Generator Partnership and OMNI360 Launch
Aug. 6, 2026

Acorn’s Q2 EPS of $0.12 Reflects Increasing High-Margin, Recurring Monitoring Revenue; Growth Initiatives Include New Generator Partnership and OMNI360 Launch

Indeterminate GlobeNewswire
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
Aug. 6, 2026

argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.

Indeterminate GlobeNewswire
Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
Aug. 6, 2026

Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

Indeterminate GlobeNewswire
BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease
Aug. 6, 2026

BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease

Indeterminate GlobeNewswire
ZenaTech Closes 27th Drone as a Service Acquisition Expanding into Idaho, Strengthening Drone-Based Surveying and Civil Engineering Services for Government and Construction Customers
Aug. 6, 2026

ZenaTech Closes 27th Drone as a Service Acquisition Expanding into Idaho, Strengthening Drone-Based Surveying and Civil Engineering Services for Government and Construction Customers

Indeterminate GlobeNewswire
Parker Reports Record Fiscal 2026 Fourth Quarter and Full Year Results
Aug. 6, 2026

Parker Reports Record Fiscal 2026 Fourth Quarter and Full Year Results

Indeterminate GlobeNewswire
Martin Eade and Natalie Southgate Launch Still Not Dead Podcast, Reaching the Top 10% of New Podcasts Globally Within Its First Week
Aug. 6, 2026

Martin Eade and Natalie Southgate Launch Still Not Dead Podcast, Reaching the Top 10% of New Podcasts Globally Within Its First Week

Indeterminate GlobeNewswire
Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference
Aug. 6, 2026

Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference

Indeterminate GlobeNewswire
Ocugen Provides Business Update with Second Quarter 2026 Financial Results
Aug. 6, 2026

Ocugen Provides Business Update with Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates
Aug. 6, 2026

Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates

Indeterminate GlobeNewswire
Immunocore reports second quarter financial results and provides a business update
Aug. 6, 2026

Immunocore reports second quarter financial results and provides a business update

Indeterminate GlobeNewswire
What Is Physical AI, and How Do Autonomous Robots Work in Factories?
Aug. 6, 2026

What Is Physical AI, and How Do Autonomous Robots Work in Factories?

Indeterminate GlobeNewswire
SEO Migration Risk: 4,000 AI Answers Tie 20-40% Traffic Loss to Execution
Aug. 6, 2026

SEO Migration Risk: 4,000 AI Answers Tie 20-40% Traffic Loss to Execution

Indeterminate GlobeNewswire
Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update
Aug. 6, 2026

Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update

Indeterminate GlobeNewswire
Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug. 6, 2026

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Aug. 6, 2026

Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
Aug. 6, 2026

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Indeterminate GlobeNewswire
Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
Aug. 6, 2026

Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Somaliland Science Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.